<DOC>
<DOCNO>EP-0651767</DOCNO> 
<TEXT>
<INVENTION-TITLE>
BIOLOGICALLY ACTIVE POLYPEPTIDES DERIVED FROM AN ACTINOMYCETE.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3800	A61K3800	A61P3100	A61P3112	C07H2100	C07H2104	C07K14195	C07K14195	C07K1436	C07K1441	C07K1441	C12N121	C12N121	C12N1509	C12N1509	C12N1531	C12N1531	C12P2104	C12P2104	C12R101	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61P	A61P	C07H	C07H	C07K	C07K	C07K	C07K	C07K	C12N	C12N	C12N	C12N	C12N	C12N	C12P	C12P	C12R	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K38	A61K38	A61P31	A61P31	C07H21	C07H21	C07K14	C07K14	C07K14	C07K14	C07K14	C12N1	C12N1	C12N15	C12N15	C12N15	C12N15	C12P21	C12P21	C12R1	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The novel polypeptide of formula (1) having anti-viral activity, its derivatives, preparation and use thereof are disclosed. The polypeptide has been isolated from the culture medium of an actinomycete.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
RHONE POULENC RORER SA
</APPLICANT-NAME>
<APPLICANT-NAME>
RHONE-POULENC RORER S.A.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
HELYNCK GERARD
</INVENTOR-NAME>
<INVENTOR-NAME>
HELYNCK, GERARD
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
